Hutch News
Results per Page:
High’d and seek: drug-specific antibodies to treat addiction and prevent overdose
From the Pancera Lab, Vaccine and Infectious Disease Division
A (literally) multi-pronged viral vaccine approach
From the McGuire Lab, Vaccine and Infectious Disease Division
Cheers to long-lived memory T cells after shingles!
From Dr. Kerry Laing and the Koelle lab, Vaccine and Infectious Disease Division
Eight Fred Hutch teams win Evergreen Fund awards
Research projects with commercial partnership potential receive grants of up to $200K
How bacteria give cancer a helping hand
Two new studies show how bugs could help tumors progress and resist treatment
A new take on having skin in the game
From the Zhu lab, Vaccine and Infectious Disease Division
Learning from the past to improve SARS-CoV-2 variant discovery
From Dr. Lue Ping Zhao and collaborating labs, Public Health Sciences, Clinical Research, and Vaccine and Infectious Disease Divisions
Does HIV disease progression differ by ancestry?
From Drs. Shuying (Sue) Li and Peter Gilbert, Vaccine and Infectious Disease Division
Community virus surveillance can double the data of vaccine trials
From Mr. Craig Magaret, Vaccine and Infectious Disease Division
Best allocation protocol for limited cholera vaccines
From the direction of Dr. Laura Matrajt, Vaccine and Infectious Disease Division
A unique population of mucosal Tregs respond to local viral infection
From the Lund and Prlic labs, Vaccine and Infectious Disease Division
Fauci visits Fred Hutch, discusses pandemics, vaccines and scientific misinformation
NIAID director’s determined spirit recognized with honorary Hutch Award
Are revisions to remdesivir dosing needed for treating SARS-CoV-2?
From the Schiffer lab, Clinical Research and Vaccine and Infectious Disease Divisions
New immunotherapy targets discovered for head and neck cancer
From the Prlic lab, Clinical Research and Vaccine and Infectious Disease Divisions
Latest Fred Hutch research on COVID-19
How Hutch scientists have been tackling coronavirus in lab and clinic
Can estrogen improve vaginal health for postmenopausal women?
From the Fredricks lab, Vaccine and Infectious Disease and Clinical Research Divisions
Optimizing antigen design may improve HIV vaccine efforts
From the Pancera, McElrath and Stamatatos labs, Vaccine and Infectious Disease and Clinical Research Divisions
Researchers advance development of potential Epstein-Barr virus vaccines
Stakes raised as common virus linked to more diseases
Test of a new 'germline-targeting' HIV vaccine prepares to launch
Vaccine’s unique protein designed to start process of building powerful antibodies against AIDS virus